Doctolib vs Infermedica (2026)
Two European health AI companies that a practice might see in the same conversation and should not evaluate the same way. Doctolib is infrastructure: the dominant booking and practice platform across France, Germany and Italy, now shipping AI capabilities inside a system practices already run, behind a security portfolio certified separately in each of the regimes that govern those markets. Infermedica is a regulated instrument: clinical triage taking a patient from an undifferentiated symptom to a level of care, certified as a Class IIb medical device in Europe. The regulatory positions differ and this index does not adjudicate device status for either. What is established is that Infermedica holds and publishes a Class IIb certificate, and that Doctolib publishes no classification or intended purpose statement for its documentation assistant or its telephone assistant. How ambient documentation is classified in Europe is a live question rather than a settled one, so treat a flat claim in either direction as something to verify for your own market. Oversight is the sharper split. Doctolib's documentation assistant puts a clinician review and signature before anything enters the record, which is published. The design behind that review is not, and the telephone assistant, which books directly into the practice system, has neither.
- It is the dominant digital health infrastructure across three European countries, so the AI reaches practices through a platform they already run rather than through a new integration.
- The security portfolio is organised by jurisdiction rather than by badge count: the information security standard certified separately in two markets, the French health data hosting certification held in its own name since 2021, the German federal cloud criteria catalogue and an Italian national cybersecurity qualification, each matching the regime that actually governs that market.
- Provenance of the core speech technology is unusually traceable, which is more than most platform vendors disclose about capability they acquired.
- Triage is the product rather than a capability inside a platform, guiding a patient from an undifferentiated symptom to a level of care over a physician curated knowledge base.
- It is certified as a Class IIb medical device in Europe, which is the correct and much higher bar for software that tells a patient how urgently to seek care.
- Being interface first means it embeds inside other organisations' products rather than requiring them to adopt a platform.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Doctolib and Infermedica are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Doctolib | Infermedica |
|---|---|---|
| Primary category | Ambient Scribes | Clinical Decision Support |
| Founded | 2013 | Not recorded |
| Headquarters | Paris, France | Not recorded |
| Website | doctolib.fr | infermedica.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Doctolib its top capability grade on AI Safety and PHI Stewardship, Security Certifications and Trust Center and EHR and Interoperability Depth. Set against Infermedica, Doctolib grades higher on Model Supply Chain Disclosure, AI Safety and PHI Stewardship and EHR and Interoperability Depth. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Infermedica its top capability grade on Security Certifications and Trust Center and Setting and Specialty Coverage. Set against Doctolib, Infermedica grades higher on AI Liability and Recourse and Setting and Specialty Coverage. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Doctolib or Infermedica?
On the axes where the AI Health Index separates them, Doctolib grades higher on Model Supply Chain Disclosure, AI Safety and PHI Stewardship and EHR and Interoperability Depth, and Infermedica grades higher on AI Liability and Recourse and Setting and Specialty Coverage. Doctolib leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Doctolib and Infermedica differ most?
The widest separation the AI Health Index records between Doctolib and Infermedica is on Setting and Specialty Coverage, where Doctolib grades C and Infermedica grades A. That axis sits in the Commercial group, so it should carry the most weight for a buyer whose binding constraint is contracting, scope and what the price actually covers.
Where do Doctolib and Infermedica grade the same?
The AI Health Index grades Doctolib and Infermedica the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
An earlier version of this comparison stated that scheduling and documentation carry no device obligation, called Doctolib's the most complete European security posture in this index, and said it publishes no oversight design at all. The first is a regulatory claim this index does not make and which its own Doctolib record contradicts, the second is a ranking, and the third overstates what is missing. Corrected 15 September 2026.
The asymmetry that matters is what each vendor publishes about its own position. Infermedica is certified as a Class IIb medical device, which is the bar that applies to software telling a patient how urgently to seek care. Doctolib publishes no classification or intended purpose statement for either AI capability. Whether ambient documentation falls inside European device regulation is contested and market specific, so ask which classification the vendor asserts in each market of interest and what post market obligations follow.
On oversight the position splits by capability. The documentation assistant places a clinician review and signature before anything enters the record, and that is published. What is not published is the review design: whether the audio or transcript stays available for checking, whether uncertain passages are flagged, and how a correction is captured. The telephone assistant publishes neither a review step nor a design, and it transfers bookings into the practice system directly.
Neither vendor publishes pricing for the AI layer, and neither publishes accuracy evidence for triage or documentation output.